Edoxaban
Back to searchMolecule Structure
Scientific Name
Edoxaban
Description of the Drug
Edoxaban is a novel oral anticoagulant used for reducing the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09075
http://www.drugbank.ca/drugs/DB09075
Brand Name(s)
Lixiana
Company Owner(s)
Daiichi Sankyo Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Coagulation factor X | SINGLE PROTEIN | INHIBITOR | CHEMBL244 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL330046 | ||
| PharmGKB | PA166128806 | ||
| DrugBank | DB09075 | ||
| PubChem: Thomson Pharma | 15285745 | ||
| PubChem | 10280735 | ||
| Nikkaji | J2.812.474K | ||
| BindingDB | 50328731 | ||
| EPA CompTox Dashboard | DTXSID50197398 | ||
| DrugCentral | 4897 | ||
| Brenda | 40399 | 77414 | |
| ChemicalBook | CB32593620 | CB21518508 | |
| Guide to Pharmacology | 7575 | ||
| rxnorm | SAVAYSA | EDOXABAN | EDOXABAN TOSYLATE |
| ChEBI | 85973 | ||
| ZINC | ZINC000043200832 |
